Document Detail


Lung function changes following methacholine inhalation in COPD.
MedLine Citation:
PMID:  19081234     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: The non-specific bronchial hyper-responsiveness reported in mild to moderate COPD is usually attributed to reduced airway calibre accentuating the effect of airway smooth muscle shortening. We hypothesized that in more severe COPD the fall in forced expiratory volume in 1 second (FEV(1)) seen during methacholine challenge would result from an increase in residual volume and decrease in vital capacity rather than an increase in airways resistance. METHODS: Twenty-five subjects with moderate to severe COPD and 10 asthmatic subjects had spirometry and oscillatory mechanics measured before methacholine challenge and at a 20% fall from baseline post challenge (PC(20)FEV(1)). RESULTS: In the COPD subjects median PC(20) was 0.35mg/mL. Comparing baseline to PC(20) there were significant falls in forced vital capacity (FVC) (2.91 vs. 2.2L; p<0.001), slow vital capacity (3.22 vs. 2.58L; p<0.001) and IC (2.21 vs. 1.75L; p<0.001) without change in FEV(1)/FVC ratio (0.52 vs. 0.52; not significant) or in total lung capacity where this was measured. Total respiratory system resistance (R(5)) was unchanged (0.66 vs. 0.68; not significant) but total respiratory system reactance decreased significantly (-0.33 vs. -0.44; p<0.001). In contrast, the asthmatics became more obstructed and showed a proportionally smaller fall in lung volume with increase in R(5) (0.43 vs. 0.64; p<0.01). CONCLUSIONS: In moderate to severe COPD the fall in FEV(1) with methacholine is mainly due to increases in residual volume, which may represent airway closure and new-onset expiratory flow limitation.
Authors:
Paul P Walker; Justine Hadcroft; Richard W Costello; Peter M A Calverley
Related Documents :
6706764 - Pleural liquid pressure gradients and intrapleural distribution of injected bolus.
7699534 - Pulmonary function abnormalities in prader-willi syndrome.
20801054 - Digital measurements of air leak flow and intrapleural pressures in the immediate posto...
18664844 - Localization and quantification of regional and segmental air trapping in asthma.
23492834 - Synthesis of novel 4-[1-(4-fluorobenzyl)-5-imidazolyl] dihydropyridines and studying th...
10469984 - Unique evolution of neurohypophysial hormones in cartilaginous fishes: possible implica...
Publication Detail:
Type:  Comparative Study; Journal Article     Date:  2008-12-10
Journal Detail:
Title:  Respiratory medicine     Volume:  103     ISSN:  1532-3064     ISO Abbreviation:  Respir Med     Publication Date:  2009 Apr 
Date Detail:
Created Date:  2009-03-02     Completed Date:  2010-02-22     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8908438     Medline TA:  Respir Med     Country:  England    
Other Details:
Languages:  eng     Pagination:  535-41     Citation Subset:  IM    
Affiliation:
Division of Infection and Immunity, School of Clinical Sciences, University of Liverpool, University Hospital Aintree, Liverpool, UK. ppwalker@liv.ac.uk
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Aged
Asthma / physiopathology*
Bronchoconstrictor Agents / diagnostic use*
England
Female
Forced Expiratory Volume / drug effects
Humans
Male
Methacholine Chloride / diagnostic use*
Middle Aged
Oscillometry
Pulmonary Disease, Chronic Obstructive / physiopathology*
Residual Volume / drug effects
Spirometry
Vital Capacity / drug effects
Chemical
Reg. No./Substance:
0/Bronchoconstrictor Agents; 62-51-1/Methacholine Chloride

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Directed differentiation of pancreatic stem cells by soluble and immobilised signalling factors.
Next Document:  Assessing the environmental impact of ashes used in a landfill cover construction.